BNP Paribas Asset Management Holding S.A. - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP Paribas Asset Management Holding S.A. ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$6,935,000
-1.7%
7,000,0000.0%0.03%
+4.0%
Q2 2021$7,052,000
-1.1%
7,000,0000.0%0.02%
-13.8%
Q1 2021$7,133,000
-5.7%
7,000,0000.0%0.03%
-17.1%
Q4 2020$7,562,000
+5.2%
7,000,0000.0%0.04%
-14.6%
Q3 2020$7,185,000
-7.0%
7,000,0000.0%0.04%
-21.2%
Q2 2020$7,728,000
+10.0%
7,000,0000.0%0.05%
-13.3%
Q1 2020$7,024,000
-12.9%
7,000,0000.0%0.06%
+9.1%
Q4 2019$8,064,000
+0.9%
7,000,0000.0%0.06%
-11.3%
Q3 2019$7,996,000
-3.4%
7,000,0000.0%0.06%
-8.8%
Q2 2019$8,279,000
-12.2%
7,000,0000.0%0.07%
-13.9%
Q1 2019$9,430,000
+28.3%
7,000,0000.0%0.08%
+16.2%
Q4 2018$7,349,000
-0.5%
7,000,0000.0%0.07%
+19.3%
Q3 2018$7,388,000
+7.4%
7,000,0000.0%0.06%
-1.7%
Q2 2018$6,877,000
-6.1%
7,000,000
-5.8%
0.06%
-6.5%
Q1 2018$7,320,000
-33.6%
7,431,000
-28.8%
0.06%
-34.0%
Q4 2017$11,017,000
-0.3%
10,431,0000.0%0.09%0.0%
Q3 2017$11,050,000
-1.8%
10,431,000
-1.6%
0.09%
-6.0%
Q2 2017$11,247,000
+9.9%
10,600,0000.0%0.10%
+6.4%
Q1 2017$10,237,000
-4.6%
10,600,0000.0%0.09%
-8.7%
Q4 2016$10,733,000
+14.9%
10,600,000
+6.0%
0.10%
+28.8%
Q3 2016$9,342,000
+31.0%
10,000,0000.0%0.08%
+33.3%
Q2 2016$7,129,000
-38.7%
10,000,000
-23.1%
0.06%
-39.4%
Q1 2016$11,635,000
-20.3%
13,000,0000.0%0.10%
-20.2%
Q4 2015$14,593,00013,000,0000.12%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2016
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders